+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Hepatitis C treatment concomitant to chemotherapy as "salvage" therapy in children with hematologic malignancies

Hepatitis C treatment concomitant to chemotherapy as "salvage" therapy in children with hematologic malignancies

Pediatric Infectious Disease Journal 29(3): 277-280

In patients with malignancies, chronic hepatitis C reactivation or severe flare is uncommon and antiviral treatment is deferred mainly due to underlying bone marrow and immune suppression. We report the use of antiviral treatment concomitantly to chemotherapy in 3 children with hematologic malignancies, chronic hepatitis C, and significant liver dysfunction.

(PDF emailed within 0-6 h: $19.90)

Accession: 053517347

Download citation: RISBibTeXText

PMID: 19949358

DOI: 10.1097/INF.0b013e3181c2115a

Related references

Surveillance and treatment protocols to detect and treat hepatitis B virus reactivation in hepatitis B surface antigen-negative/antibody to hepatitis B core antigen-positive patients receiving chemotherapy for onco-hematologic malignancies. Journal of Clinical Oncology 29(8): E210; Author Reply E211-E210; Author Reply E211, 2011

A prospective study on chemotherapy-induced hepatitis B virus reactivation in chronic HBs Ag carriers with hematologic malignancies and pre-emptive therapy with nucleoside analogues. Leukemia & Lymphoma 47(8): 1608-1612, 2006

Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies: Survey in Japan, 1987-1991. Cancer 78(10): 2210-2215, 1996

Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series. American Journal of Hematology 80(3): 197-203, 2005

Successful mobilization of hematopoietic peripheral blood progenitor cells with paclitaxel-based chemotherapy as initial or salvage regimen in patients with hematologic malignancies. Haematologica 93(9): 1436-1438, 2008

Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer. 83(6): 1224-1230,. 15, 1998

Skin manifestations associated with chemotherapy in children with hematologic malignancies. Pediatric Dermatology 29(3): 264-269, 2012

Activation of hepatitis B virus infection by chemotherapy containing glucocorticoid in hepatitis B virus carriers with hematologic malignancies. Japanese Journal of Clinical Oncology 21(5): 360-365, 1991

Hematologic malignancies /pediatric malignancies-current status of molecular target therapy for hematologic cancer. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 37(5): 805-805, 2010

Humoral immunity against hepatitis B, tetanus, and diphtheria following chemotherapy for hematologic malignancies: a report and review of literature. Pediatric Hematology and Oncology 27(3): 188-194, 2010

Efficacy of Lamivudine in patients with hematologic malignancies receiving chemotherapy and precore mutant chronic active hepatitis B. Acta Haematologica 107(1): 49-51, 2002

Incidence of hepatitis virus infection and severe liver dysfunction in patients receiving chemotherapy for hematologic malignancies. European Journal of Haematology 67(1): 45-50, July, 2001